Can a smartphone app objectively measure ADHD treatment success?

NCT ID NCT07217977

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Qbtech AB Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a digital tool called QbMobile can accurately measure changes in ADHD symptoms after starting treatment. Researchers will enroll 175 people aged 6 to 60 who are newly diagnosed or not yet on medication. Participants use QbMobile to generate a symptom score, which is tracked over time to see if it reflects treatment effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could provide doctors with a more objective way to monitor ADHD treatment response, potentially improving care.
What could go wrong: This is an observational study, not a treatment trial. It only tests a monitoring tool, so it won't directly improve symptoms. Results may not change current practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATTENTION DEFICIT DISORDER (ADD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

attention deficit hyperactivity disorder, inattentive type attention deficit-hyperactivity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATTENTION DEFICIT DISORDER (ADD) ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY (ADHD)

Contacts and locations

Locations

Bokhari Medical Consortium

Largo, Florida, 33770, United States
CCM Clinical Research Group

Miami, Florida, 33133, United States
Focus-MD

Mobile, Alabama, 36607, United States
Godwin Psychiatry

Goldsboro, North Carolina, 27534, United States
MindWell Urgent Care

Dallas, Texas, 75247, United States
Nona Pediatric Center

Orlando, Florida, 32829, United States
Prodigy Psychiatric Group

San Jose, California, 95138, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.